AIM: To assess the functional status and etiology of liver cirrhosis by quantitative (31)P magnetic resonance spectroscopy (MRS). METHODS: A total of 80 patients with liver cirrhosis of different etiology and functional status described by Child-Pugh score were examined and compared to 11 healthy volunteers. MR examination was performed on a 1.5 T imager using a (1)H/(31)P surface coil by the 2D chemical shift imaging technique. Absolute concentrations of phosphomonoesters (PME), phosphodiesters (PDE), inorganic phosphate (Pi) and adenosine triphosphate (ATP) were measured. RESULTS: MRS changes reflected the degree of liver dysfunction in all the patients as well as in individual etiological groups. The most important change was a decrease of PDE. It was possible to distinguish alcoholic, viral and cholestatic etiologies based on MR spectra. Alcoholic and viral etiology differed in PDE (alcoholic, viral, controls: 6.5+/-2.3, 6.5+/-3.1, 10.8+/-2.7 mmol/L, P<0.001) and ATP (alcoholic, viral, controls: 2.9+/-0.8, 2.8+/-0.9, 3.7+/-1.0 mmol/L, P<0.01) from the control group. Unlike viral etiology, patients with alcoholic etiology also differed in Pi (alcoholic, controls: 1.2+/-0.4, 1.6+/-0.6 mmol/L, P<0.05) from controls. No significant changes were found in patients with cholestatic disease and controls; nevertheless, this group differed from both alcoholic and viral groups (cholestatic, alcoholic, viral: 9.4+/-2.7, 6.5+/-2.3, 6.5+/-3.1 mmol/L, P<0.005) in PDE. CONCLUSION: (31)P MRS can significantly help in non-invasive separation of different etiological groups leading to liver cirrhosis. In addition, MRS changes reflect functional liver injury.

MR Unit Department of Diagnostic and Interventional Radiology; Institute for Clinical and Experimental Medicine Prague Czech Republic

Zobrazit více v PubMed

Child CG, Turcotte JG. Surgery and portal hypertension. In child CG. The liver and portal hypertension. 1st ed. Philadelphia. WB Saunders Co. 1968. pp. 50–72.

Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649. PubMed

Christensen E, Schlichting P, Fauerholdt L, Gluud C, Andersen PK, Juhl E, Poulsen H, Tygstrup N. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology. 1984;4:430–435. PubMed

Montgomery Bissel D, Maher JJ. Hepatic fibrosis and cirrhosis. In: Zakim D, Boyer TD, editors. Hepatology, a textbook of liver disease. 4th ed. Philadelphia: Saunders; 2002. pp. 395–416.

de Graff RA. In vivo NMR Spectroscopy: Principles and Techniques. 1st ed. Chichester: John Wiley & Sons; 1998.

Meyerhoff DJ, Boska MD, Thomas AM, Weiner MW. Alcoholic liver disease: quantitative image-guided P-31 MR spectroscopy. Radiology. 1989;173:393–400. PubMed

Munakata T, Griffiths RD, Martin PA, Jenkins SA, Shields R, Edwards RH. An in vivo 31P MRS study of patients with liver cirrhosis: progress towards a non-invasive assessment of disease severity. NMR Biomed. 1993;6:168–172. PubMed

Angus PW, Dixon RM, Rajagopalan B, Ryley NG, Simpson KJ, Peters TJ, Jewell DP, Radda GK. A study of patients with alcoholic liver disease by 31P nuclear magnetic resonance spectroscopy. Clin Sci (Lond) 1990;78:33–38. PubMed

Menon DK, Sargentoni J, Taylor-Robinson SD, Bell JD, Cox IJ, Bryant DJ, Coutts GA, Rolles K, Burroughs AK, Morgan MY. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology. 1995;21:417–427. PubMed

Taylor-Robinson SD, Sargentoni J, Bell JD, Saeed N, Changani KK, Davidson BR, Rolles K, Burroughs AK, Hodgson HJ, Foster CS, et al. In vivo and in vitro he patic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver. 1997;17:198–209. PubMed

Tosner Z, Dezortová M, Tintĕra J, Hájek M. Application of two-dimensional CSI for absolute quantification of phosphorus metabolites in the human liver. MAGMA. 2001;13:40–46. PubMed

Murphy-Boesch J, Jiang H, Stoyanova R, Brown TR. Quantification of phosphorus metabolites from chemical shift imaging spectra with corrections for point spread effects and B1 inhomogeneity. Magn Reson Med. 1998;39:429–438. PubMed

Available from: http: //www.statsoft.com/textbook/stathome.html.

Meloun M, Militky J. Statisticka analyza experimentalnich dat. (Cz) (Statistical analysis of experimental data.) 1st ed. Academia. 2004.

Available from: http: //www.eletel.P.lodz.pl/cost/cost_project.html.

Sijens PE, Dagnelie PC, Halfwerk S, van Dijk P, Wicklow K, Oudkerk M. Understanding the discrepancies between 31P MR spectroscopy assessed liver metabolite concentrations from different institutions. Magn Reson Imaging. 1998;16:205–211. PubMed

Miyamoto K, French SW. Hepatic adenine nucleotide metabolism measured in vivo in rats fed ethanol and a high fat-low protein diet. Hepatology. 1988;8:53–60. PubMed

Corbin IR, Buist R, Peeling J, Zhang M, Uhanova J, Minuk GY. Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease. Gut. 2003;52:1046–1053. PubMed PMC

Jalan R, Taylor-Robinson SD, Hodgson HJ. In vivo hepatic magnetic resonance spectroscopy: clinical or research tool? J Hepatol. 1996;25:414–424. PubMed

Kiyono K, Shibata A, Sone S, Watanabe T, Oguchi M, Shikama N, Ichijo T, Kiyosawa K, Sodeyama T. Relationship of 31P MR spectroscopy to the histopathological grading of chronic hepatitis and response to therapy. Acta Radiol. 1998;39:309–314. PubMed

Lim AK, Patel N, Hamilton G, Hajnal JV, Goldin RD, Taylor-Robinson SD. The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology. 2003;37:788–794. PubMed

In Vitro 31P MR Chemical Shifts of In Vivo-Detectable Metabolites at 3T as a Basis Set for a Pilot Evaluation of Skeletal Muscle and Liver 31P Spectra with LCModel Software